Source:http://linkedlifedata.com/resource/pubmed/id/11363352
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1996-5-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
X
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11363352-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:11363352-Antiviral Agents,
pubmed-meshheading:11363352-CD4 Lymphocyte Count,
pubmed-meshheading:11363352-Didanosine,
pubmed-meshheading:11363352-Drug Therapy, Combination,
pubmed-meshheading:11363352-Humans,
pubmed-meshheading:11363352-Zalcitabine,
pubmed-meshheading:11363352-Zidovudine
|
pubmed:year |
1995
|
pubmed:articleTitle |
ACTG 175: new insights into treating patients with intermediate-stage HIV disease.
|
pubmed:publicationType |
Newspaper Article
|